Neil M Kogut

Title(s)Assistant Adjunct Professor, Urology
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance. Transplantation. 2023 02 01; 107(2):504-510. Sosa RA, Mone T, Naini BV, Kohn DB, Reed EF, Wheeler K, Campo-Fernandez B, Davila A, Chaffin DJ, DiNorcia J, Kaldas FM, Cohen A, Lum EL, Veale JL, Kogut NM. PMID: 35974436; PMCID: PMC9877104.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Immune tolerance induction through haematopoietic chimerism after kidney donation. Lancet. 2022 08 06; 400(10350):e2. Nassiri N, Lum E, Mead MD, Raldow AC, Kogut N, Veale JL. PMID: 35934008.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports. Transplant Direct. 2017 Aug; 3(8):e200. Lum EL, Kogut N, Pham T, Danovitch GM, Bunnapradist S. PMID: 28795151; PMCID: PMC5540638.
      View in: PubMed   Mentions: 7  
    4. Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent. Transfusion. 2013 Dec; 53(12):3244-50. Yuan S, Nademanee A, Krishnan A, Kogut N, Shayani S, Wang S. PMID: 23607889.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies. Leukemia. 2013 Apr; 27(5):1139-45. Vanderwalde AM, Sun CL, Laddaran L, Francisco L, Armenian S, Berano-Teh J, Wong FL, Popplewell L, Somlo G, Stein AS, Nademanee A, Krishnan A, Kogut N, Forman SJ, Bhatia S. PMID: 23183426; PMCID: PMC3776451.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    6. Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia. Leuk Lymphoma. 2013 Mar; 54(3):665-8. Kogut N, Tsai NC, Thomas SH, Palmer J, Paris T, Murata-Collins J, Forman SJ. PMID: 22906206; PMCID: PMC3521076.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant. 2012 Mar; 18(3):486-92. Sahebi F, Frankel PH, Farol L, Krishnan AY, Cai JL, Somlo G, Thomas SH, Reburiano E, Popplewell LL, Parker PM, Spielberger RT, Kogut NM, Karanes C, Htut M, Ruel C, Duarte L, Murata-Collins JL, Forman SJ. PMID: 22198542.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    8. Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control. Leuk Lymphoma. 2011 Aug; 52(8):1463-73. Zain J, Palmer JM, Delioukina M, Thomas S, Tsai NC, Nademanee A, Popplewell L, Gaal K, Senitzer D, Kogut N, O'Donnell M, Forman SJ. PMID: 21699453; PMCID: PMC3441144.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    9. High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors. Biol Blood Marrow Transplant. 2011 Oct; 17(10):1481-9. Nademanee A, Palmer JM, Popplewell L, Tsai NC, Delioukina M, Gaal K, Cai JL, Kogut N, Forman SJ. PMID: 21338704; PMCID: PMC3570567.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    10. Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma. Ann Hematol. 2011 Jul; 90(7):803-8. Chen R, Palmer JM, Popplewell L, Shen J, Smith E, Delioukina M, Kogut N, Rosenthal J, Forman S, Nademanee A. PMID: 21210120.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    11. Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma. Clin Cancer Res. 2011 Jan 01; 17(1):174-82. Somlo G, Spielberger R, Frankel P, Karanes C, Krishnan A, Parker P, Popplewell L, Sahebi F, Kogut N, Snyder D, Liu A, Schultheiss T, Forman S, Wong JY. PMID: 21047977; PMCID: PMC3717559.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    12. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood. 2010 Feb 04; 115(5):1098-105. Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A, Snyder D, Pullarkat V, Kogut N, Rosenthal J, Smith E, Karanes C, O'Donnell M, Krishnan AY, Senitzer D, Forman SJ. PMID: 19965688; PMCID: PMC2817636.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    13. Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2009 Nov; 15(11):1407-14. Stein AS, Palmer JM, O'Donnell MR, Kogut NM, Spielberger RT, Slovak ML, Tsai NC, Senitzer D, Snyder DS, Thomas SH, Forman SJ. PMID: 19822300; PMCID: PMC2795637.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    14. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. Bone Marrow Transplant. 2007 Nov; 40(9):843-50. Nakamura R, Rodriguez R, Palmer J, Stein A, Naing A, Tsai N, Chang K, Slovak ML, Bhatia R, Spielberger R, Kogut N, Pullarkat V, Kirschbaum M, Forman SJ, O'Donnell MR. PMID: 17724447.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    15. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Transfusion. 2007 Dec; 47(12):2207-16. Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S. PMID: 17714420.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma. Biol Blood Marrow Transplant. 2007 May; 13(5):594-600. Fung HC, Stiff P, Schriber J, Toor A, Smith E, Rodriguez T, Krishnan A, Molina A, Smith D, Ivers B, Kogut N, Popplewell L, Rodriguez R, Somlo G, Forman SJ, Nademanee A. PMID: 17448919.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    17. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2006 Dec; 12(12):1326-34. Rodriguez R, Nademanee A, Ruel N, Smith E, Krishnan A, Popplewell L, Zain J, Patane K, Kogut N, Nakamura R, Sarkodee-Adoo C, Forman SJ. PMID: 17162215.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    18. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? Biol Blood Marrow Transplant. 2006 Jun; 12(6):641-7. Krishnan A, Nademanee A, Fung H, Angelopoulou M, Molina A, Gaal K, Dagis A, Palmer J, Alvarnas J, Slovak M, Kogut N, Popplewell L, Rodriguez R, Schriber J, Wang S, Forman SJ. PMID: 16737937.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. Bone Marrow Transplant. 2006 May; 37(9):825-9. Sahebi F, Spielberger R, Kogut NM, Fung H, Falk PM, Parker P, Krishnan A, Rodriguez R, Nakamura R, Nademanee A, Popplewell L, Frankel P, Ruel C, Tin R, Ilieva P, Forman SJ, Somlo G. PMID: 16565743.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    20. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer. Biol Blood Marrow Transplant. 2005 Nov; 11(11):903-11. Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S. PMID: 16275593.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    21. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. Blood. 2005 Oct 15; 106(8):2896-902. Nademanee A, Forman S, Molina A, Fung H, Smith D, Dagis A, Kwok C, Yamauchi D, Anderson AL, Falk P, Krishnan A, Kirschbaum M, Kogut N, Nakamura R, O'donnell M, Parker P, Popplewell L, Pullarkat V, Rodriguez R, Sahebi F, Smith E, Snyder D, Stein A, Spielberger R, Zain J, White C, Raubitschek A. PMID: 16002426; PMCID: PMC1895300.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    22. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Apr; 11(4):307-13. Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadhimi Z, Bhatia R, Cohen S, Falk P, Fung H, Kirschbaum M, Krishnan A, Kogut N, Molina A, Nakamura R, O'Donnell M, Popplewell L, Pullarkat V, Rosenthal J, Sahebi F, Smith E, Snyder D, Somlo G, Spielberger R, Stein A, Sweetman R, Zain J, Forman S. PMID: 15812396.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    23. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005 Jan 15; 105(2):874-8. Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N, Falk PM, Rosenthal J, Alvarnas J, Forman SJ. PMID: 15388574.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    24. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. Bone Marrow Transplant. 2004 Jun; 33(11):1123-9. Rodriguez R, Parker P, Nademanee A, Smith D, O'Donnell MR, Stein A, Snyder DS, Fung HC, Krishnan AY, Popplewell L, Cohen S, Somlo G, Angelopoulou M, Al-Kadhimi Z, Falk PM, Spielberger R, Kogut N, Sahebi F, Senitzer D, Slovak M, Schriber J, Forman SJ. PMID: 15064696.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    25. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy. J Clin Oncol. 2004 May 15; 22(10):1839-48. Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R, Shibata S, Chu P, Forman S, Lim D, Twardowski P, Weitzel J, Alvarnas J, Kogut N, Schriber J, Fermin E, Yen Y, Damon L, Doroshow JH. PMID: 15143076.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    26. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant. 2003 Dec; 9(12):766-71. Fung HC, Stein A, Slovak Ml, O'donnell MR, Snyder DS, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E, Forman SJ. PMID: 14677116.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    27. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. Biol Blood Marrow Transplant. 2003 Oct; 9(10):649-56. Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O'Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ. PMID: 14569561.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    28. Autologous stem cell transplantation for HIV-associated lymphoma. Blood. 2001 Dec 15; 98(13):3857-9. Krishnan A, Molina A, Zaia J, Nademanee A, Kogut N, Rosenthal J, Woo D, Forman SJ. PMID: 11739198.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    29. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up. Gynecol Oncol. 2000 Jun; 77(3):433-8. Morgan RJ, Braly P, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Najera L, Johnson D, Doroshow JH. PMID: 10831355.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    30. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up. Gynecol Oncol. 1999 Dec; 75(3):419-26. Morgan RJ, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH. PMID: 10600300.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    31. Mucormycosis of the vulva following bone marrow transplantation. Bone Marrow Transplant. 1997 Apr; 19(8):859-60. Nomura J, Ruskin J, Sahebi F, Kogut N, Falk PM. PMID: 9134185.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    32. A comparison of single-dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation. Int J Radiat Oncol Biol Phys. 1996 Aug 01; 36(1):61-6. Morgan TL, Falk PM, Kogut N, Shah KH, Tome M, Kagan AR. PMID: 8823259.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    33. True histiocytic malignancy associated with a malignant teratoma in a patient with 46XY gonadal dysgenesis. Am J Surg Pathol. 1992 Feb; 16(2):175-83. Koo CH, Reifel J, Kogut N, Cove JK, Rappaport H. PMID: 1346359.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Neil's Networks
    Concepts (177)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California